Ranbaxy Laboratories Limited, INDIA
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- GESTID chewable tablet
- HISTAC film-coated tablet 150 mg
- HISTAC film-coated tablet 300 mg
- RANOXYL capsule, hard 500 mg
- A05 - Terapia biliar y hepática
- SIVYLAR capsule, hard 140 mg
- SIVYLAR capsule, hard 70 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- INVORIL tablet 10 mg
- INVORIL tablet 20 mg
- INVORIL tablet 5 mg
- C10 - Agentes modificadores de los lípidos
- SIMVOR film-coated tablet 10 mg
- SIMVOR film-coated tablet 20 mg
- J01 - Antibacterianos para uso sistémico
- CEROXIM tablet 250 mg
- CEROXIM tablet 500 mg
- CIFRAN film-coated tablet 250 mg
- CIFRAN film-coated tablet 500 mg
- ENHANCIN film-coated tablet 250 mg+125 mg
- ENHANCIN film-coated tablet 500 mg+125 mg
- ENHANCIN powder for oral suspension 125 mg/5 ml+31.25 mg/5 ml
- ENHANCIN powder for oral suspension 250 mg/5 ml+62.5 mg/5 ml
- KEFLOXIN capsule, hard 500 mg
- SPORIDEX capsule, hard 250 mg
- SPORIDEX capsule, hard 500 mg
- SPORIDEX powder for oral suspension 125 mg/5 ml
- SPORIDEX powder for oral suspension 250 mg/5 ml
- VERCEF capsule, hard 500 mg
- VERCEF granules for oral suspension 125 mg/5 ml
- VERCEF granules for oral suspension 250 mg/5 ml
- J05 - Antivirales de uso sistémico
- LOVIR tablet 200 mg
- LOVIR tablet 400 mg
- LOVIR tablet 800 mg
- N06 - Psicoanalépticos
- FLURAN capsule, hard 20 mg
- GINKOCER film-coated tablet 40 mg
- R06 - Antihistamínicos para uso sistémico
- ROLETRA tablet 10 mg